Background illustration for clinical trials search

Multiple Sclerosis Clinical Trials

Browse 309 multiple sclerosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS

for
Multiple Sclerosis
Location: Naples FL
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All

Age: 0+

Code: NCT05003388

Phase 1, Recruiting

Fall Risk Reduction in Multiple Sclerosis (FIRMS)

for
Multiple Sclerosis
Location: Urbana IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 18 - 64

Code: NCT02314585

Recruiting

Physiology of Interregional Connectivity in the Human Brain

for
Healthy, Stroke, Traumatic Brain Injury, Multiple Sclerosis
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab

Sex: All

Age: 18 - 70+

Code: NCT03723434

Recruiting

A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets

for
Multiple Sclerosis
Location: Latham NY
Sponsor: Keith Edwards, M.D.

Sex: All

Age: 21 - 65

Code: NCT04550455

Recruiting

Effects of Spinal Cord Injury on Female Sexual Response

for
Female Sexual Dysfunction, Multiple Sclerosis,
Location: Birmingham AL
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: Female

Age: 18 - 55

Code: NCT00142714

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis

for
Multiple Sclerosis
Location: Philadelphia PA
Sponsor: Multiple Sclerosis Institute

Sex: All

Age: 18 - 55

Code: NCT00217295

Phase 2, Recruiting

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

for
Multiple Sclerosis (MS), Fatigue, Physical Inactivity
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06270641

Recruiting

Novel Immune Markers in Patients With Multiple Sclerosis

for
Multiple Sclerosis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 21 - 50

Code: NCT01026272

Recruiting

" Treating MS Patients With Lower Extremity Spasticity Using Dysport"

for
Multiple Sclerosis, Spasticity, Muscle
Location: Foxboro MA
Sponsor: Neurology Center of New England P.C.

Sex: All

Age: 0+

Code: NCT03585569

Phase 3, Recruiting

Clinical Applications of Advanced Ophthalmic Imaging

for
Multiple Sclerosis, Dry Eye Syndromes, Diabetic Retinopathy,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18 - 70+

Code: NCT03135327

Recruiting

Low Fat Diet for Fatigue in MS

for
Multiple Sclerosis
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70

Code: NCT03322982

Recruiting

Entire-body PET Scans for Multiple Sclerosis

for
Multiple Sclerosis
Location: Ladera Ranch CA
Sponsor: Brain Health Alliance

Sex: All

Age: 25 - 55

Code: NCT04390009

Early Phase 1, Recruiting

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

for
Multiple Sclerosis
Location: Foxborough MA, Teaneck NJ, Abington PA, Baltimore MD,
Sponsor: Sanofi

Sex: All

Age: 18 - 60

Code: NCT07325292

Phase 3, Recruiting

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07779460

Recruiting

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

for
Multiple Sclerosis
Location: Montreal
Sponsor: Innodem Neurosciences

Sex: All

Age: 18+

Code: NCT05061953

Recruiting

Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis

for
Multiple Sclerosis
Location: Hartford CT
Sponsor: Mount Sinai Rehabilitation Hospital

Sex: All

Age: 18 - 65

Code: NCT02759211

Recruiting

Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses

for
Multiple Sclerosis
Location: New York NY
Sponsor: Aaron Miller

Sex: All

Age: 18 - 65

Code: NCT01900093

Recruiting
New

A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

for
Muscular Dystrophies,
Location: London
Sponsor: Avidity Biosciences, Inc.

Sex: Male

Age: 7 - 16

Code: NCT07587242

Phase 3, Recruiting

A Multicenter Pediatric Deep Brain Stimulation Registry

for
Dystonia, Epilepsy in Children, Cerebral Palsy,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 18

Code: NCT06585618

Recruiting

Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology

for
Healthy, Cognitive Impairment, Neurological Disorder
Location: Chicago IL, Skokie IL
Sponsor: ElMindA Ltd

Sex: All

Age: 8 - 70+

Code: NCT03699514

Recruiting

What is multiple sclerosis?

In MS, the immune system attacks myelin, the insulation around nerve fibers in the brain and spinal cord. Damaged spots, called lesions, slow or block nerve signals, which is why symptoms range from fatigue and numbness to vision problems and trouble walking. Symptoms and pace differ so much between people that MS is often called a disease with a thousand faces. It is not contagious, and it is not directly inherited. Worldwide about 2.9 million people live with MS, someone is diagnosed roughly every five minutes, and the average age at diagnosis is 32.

Research in this field carries one of the most striking findings in modern medicine: a 2022 study of more than 10 million US military members found that infection with the Epstein Barr virus, the common virus behind mononucleosis, raises MS risk 32 times, making it the leading suspected cause. Meanwhile treatment keeps expanding, with more than 20 approved disease modifying therapies, though the progressive forms still have almost none.

Article preview image

Interested in learning more about MS treatment? Read our guide: Multiple Sclerosis Treatment: 20+ Drugs and What's Next

Why Progressive Multiple Sclerosis Still Has Almost No Approved Treatments

The types of MS, and why they matter for trials

Types of multiple sclerosis clinical trials

Who can participate in MS trials?

Do MS trial participants get paid?

How to enroll in a clinical trial for multiple sclerosis